CareDx Shares Outstanding 2013-2025 | CDNA
CareDx shares outstanding from 2013 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| CareDx Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 57 |
| 2023 | 54 |
| 2022 | 53 |
| 2021 | 52 |
| 2020 | 46 |
| 2019 | 42 |
| 2018 | 36 |
| 2017 | 23 |
| 2016 | 16 |
| 2015 | 12 |
| 2014 | 9 |
| 2013 | 1 |
| 2012 | 1 |
| CareDx Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-03-31 | 55 |
| 2024-12-31 | 57 |
| 2024-09-30 | 53 |
| 2024-06-30 | 52 |
| 2024-03-31 | 52 |
| 2023-12-31 | 54 |
| 2023-09-30 | 54 |
| 2023-06-30 | 54 |
| 2023-03-31 | 54 |
| 2022-12-31 | 53 |
| 2022-09-30 | 53 |
| 2022-06-30 | 53 |
| 2022-03-31 | 53 |
| 2021-12-31 | 52 |
| 2021-09-30 | 53 |
| 2021-06-30 | 52 |
| 2021-03-31 | 51 |
| 2020-12-31 | 46 |
| 2020-09-30 | 49 |
| 2020-06-30 | 45 |
| 2020-03-31 | 43 |
| 2019-12-31 | 42 |
| 2019-09-30 | 42 |
| 2019-06-30 | 42 |
| 2019-03-31 | 42 |
| 2018-12-31 | 36 |
| 2018-09-30 | 37 |
| 2018-06-30 | 36 |
| 2018-03-31 | 30 |
| 2017-12-31 | 23 |
| 2017-09-30 | 23 |
| 2017-06-30 | 21 |
| 2017-03-31 | 21 |
| 2016-12-31 | 16 |
| 2016-09-30 | 19 |
| 2016-06-30 | 14 |
| 2016-03-31 | 12 |
| 2015-12-31 | 12 |
| 2015-09-30 | 12 |
| 2015-06-30 | 12 |
| 2015-03-31 | 12 |
| 2014-12-31 | 9 |
| 2014-09-30 | 11 |
| 2014-06-30 | 7 |
| 2014-03-31 | 1 |
| 2013-12-31 | 1 |
| 2013-09-30 | 1 |
| 2013-06-30 | 1 |
| 2013-03-31 | 1 |
| 2012-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.088B | $0.334B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.373B | 26.51 |
| Elevance Health (ELV) | United States | $87.880B | 11.34 |
| CVS Health (CVS) | United States | $87.261B | 10.85 |
| Cencora (COR) | United States | $58.118B | 20.22 |
| Natera (NTRA) | United States | $23.068B | 0.00 |
| DiDi Global (DIDIY) | China | $23.062B | 24.50 |
| Labcorp Holdings (LH) | United States | $21.972B | 17.82 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.845B | 0.00 |
| Solventum (SOLV) | United States | $13.121B | 13.89 |
| CochLear (CHEOY) | Australia | $12.902B | 0.00 |
| ICON (ICLR) | Ireland | $11.746B | 10.92 |
| Revvity (RVTY) | United States | $11.400B | 19.62 |
| Viatris (VTRS) | United States | $10.481B | 3.60 |
| Avantor (AVTR) | United States | $9.172B | 13.33 |
| HealthEquity (HQY) | United States | $9.059B | 39.68 |
| Medpace Holdings (MEDP) | United States | $9.021B | 23.96 |
| Sonic Healthcare (SKHHY) | Australia | $8.561B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.452B | 14.60 |
| Caris Life Sciences,�Inc (CAI) | $6.798B | 0.00 | |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.602B | 27.10 |
| BrightSpring Health Services (BTSG) | United States | $4.147B | 38.05 |
| Sotera Health (SHC) | United States | $3.156B | 17.93 |
| Surgery Partners (SGRY) | United States | $2.849B | 37.05 |
| Alignment Healthcare (ALHC) | United States | $2.770B | 0.00 |
| Concentras Parent (CON) | United States | $2.637B | 15.24 |
| GeneDx Holdings (WGS) | United States | $2.634B | 101.44 |
| Organon (OGN) | United States | $2.516B | 2.67 |
| PACS (PACS) | United States | $1.969B | 0.00 |
| Ardent Health (ARDT) | United States | $1.954B | 8.33 |
| Progyny (PGNY) | United States | $1.886B | 41.51 |
| Premier (PINC) | United States | $1.806B | 13.71 |
| GoodRx Holdings (GDRX) | United States | $1.779B | 35.57 |
| Teladoc Health (TDOC) | United States | $1.528B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.235B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.233B | 9.38 |
| Agilon Health (AGL) | United States | $0.952B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.791B | 7.41 |
| Nutex Health (NUTX) | United States | $0.692B | 10.47 |
| LifeMD (LFMD) | United States | $0.619B | 0.00 |
| Embecta (EMBC) | United States | $0.566B | 3.82 |
| InnovAge Holding (INNV) | United States | $0.498B | 0.00 |
| Enhabit (EHAB) | United States | $0.488B | 40.17 |
| SBC Medicals (SBC) | United States | $0.481B | 0.00 |
| Omada Health (OMDA) | $0.471B | 0.00 | |
| Sonida Senior Living (SNDA) | United States | $0.471B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.459B | 10.33 |
| So-Young (SY) | China | $0.314B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.313B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.262B | 0.00 |
| Beauty Health (SKIN) | United States | $0.241B | 0.00 |
| Oncology Institute (TOI) | United States | $0.183B | 0.00 |
| DocGo (DCGO) | United States | $0.160B | 26.17 |
| Pheton Holdings (PTHL) | China | $0.121B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.104B | 0.00 |
| KindlyMD (NAKA) | United States | $0.083B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| ModivCare (MODV) | United States | $0.045B | 0.00 |
| Biodesix (BDSX) | United States | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.033B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.027B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |